China Life Insurance (Group) Company, headquartered in Beijing, is the largest commercial insurance group in Mainland China and the only state-owned insurance entity with assets exceeding 1 trillion RMB. Established in 1949 and restructured in 2003, China Life offers a comprehensive range of services including individual and group life insurance, accident and health insurance, pension plans, and asset management. The company commands approximately 20% of the life insurance market share in China, with life premium income significantly contributing to its revenue. It operates through various subsidiaries, which include China Life Insurance Company Limited and China Life Asset Management Company Limited, while also being a major institutional investor in China's capital markets. China Life is actively focusing on developing a senior-care ecosystem and enhancing its agent team to ensure sustainable long-term growth.
Executive Director, Fixed Income Portfolio Manager
Liu Huimin
Vice President
Miao Jianmin
Vice Chairman, President, Director
Cui Lanqin
Vice President
Wang Sidong
Vice President
Zhang Xiangxian
Vice President
Mingsheng Yang
Chairman
H.C. Tung
Founder
16 past transactions
COFCO Fortune
Private Equity Round in 2023
COFCO Fortune provides high-quality food to customers through a fully integrated value chain with many well-known retailers and other state-owned enterprises.
Jiangsu Hanbon Science & Technology Co., Ltd is an import and export company specializing in the research, development, manufacture, and sale of chromatography-related products. Founded in 1998 and based in Huai'an City, China, the company offers a wide range of equipment for liquid chromatography, including simulated moving bed systems, dynamic axial compression columns, UV analytical detectors, and various pumps and filtration systems. Hanbon also provides chromatography accessories, consumables, and reagents, catering to the needs of the biomedical industry for laboratory analysis and scale-up testing. The company has established a presence with offices in multiple cities across China, including Shanghai, Guangzhou, and Wuhan, facilitating its outreach and service capabilities in the market.
Saint Bella is a maternal and baby care center operator based in Zhuhai City, China, founded in 2017. The company specializes in prenatal and postpartum care, offering a range of services that include mother and child care, art therapy, and lunar nursing care. Saint Bella aims to support the health and well-being of mothers and their children through comprehensive care solutions.
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. The company's software helps pharmaceutical companies accelerate the movement of new drugs in the pipeline through optimizing pre-clinical trial operations, enabling users to efficiently conduct research and design.
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Xinyi Energy Holdings Limited is an investment holding company that specializes in the ownership, operation, and management of solar farms in the People's Republic of China. The company currently operates 16 solar farm projects with a total approved capacity of 1,514 megawatts, strategically located in provinces such as Anhui, Hubei, Henan, Fujian, and Tianjin, which have a strong demand for electricity. Xinyi Energy generates revenue primarily from the sale of electricity to local subsidiaries of the State Grid, along with management fees from providing operational services for solar farms. The company has a track record of avoiding power curtailment issues during its operational history. Established in 2015 and headquartered in Wuhu, Xinyi Energy is a subsidiary of Xinyi Solar Holdings Limited, and it aims to maintain a high dividend payout ratio, intending to distribute not less than 90% of its distributable income each financial year.
Vazyme Biotech Co., Ltd. is a biotechnology company based in Nanjing, China, founded in 2012. The company specializes in the development and production of enzymes and antibodies, with applications across various fields including clinical diagnosis, molecular diagnostics, high-throughput sequencing, and life science research. Vazyme Biotech is recognized for its advanced research and development capabilities and employs cutting-edge technology to innovate within the biotechnology sector. Its strategic location in the National Economic and Technological Development Zone of Nanjing allows the company to leverage regional resources and expertise, positioning it to play a significant role in the national biotechnology landscape.
JUSDA, a service platform of supply chain management for Foxconn Technology Group and a pilot in integrating C2C (Component to Consumer) supply chain services around the world, is committed to driving professionalism and growth of supply chain management by advanced technology and R&D. The company applies an innovative business model that covers trading flow, goods flow, information flow, capital flow, technology flow and process flow.
JD.com is a leading online direct sales company in China, renowned for its extensive transaction volume and significant market share. The platform provides consumers with a diverse selection of authentic products at competitive prices, emphasizing a user-friendly online shopping experience through its website and mobile applications. To ensure timely and reliable delivery, JD.com has established a comprehensive nationwide fulfillment infrastructure, comprising numerous warehouses and a self-operated delivery network. This infrastructure allows the company to maintain high customer satisfaction levels and supports both its direct sales and online marketplace operations. JD.com also includes JD Health, an e-commerce platform for pharmaceutical products, and JD Logistics, which offers supply chain and logistics services, including innovative solutions like drone deliveries. With a strong emphasis on technology, JD.com has invested in a proprietary platform to facilitate growth and enhance service offerings, employing a substantial workforce to support its operations across China.
United Imaging Healthcare develops and manufactures a wide range of medical equipment and solutions, focusing on diagnostic imaging, radiotherapy, and healthcare information technology. The company's product offerings include advanced imaging devices such as computed tomography, molecular imaging, magnetic resonance systems, and digital radiography solutions. Notable products include the uCT 510, uMI 510 PET-CT scanner, and uMR 560 imaging device. Additionally, United Imaging provides the uCloud UIH Intelligent Medical Cloud platform for resource sharing and data analysis. The company also offers comprehensive customer support, technical assistance, and training services. Established in 2011 and headquartered in Shanghai, China, United Imaging Healthcare has expanded its operations to various locations, including the United States, with facilities in cities like Concord, Cleveland, and Houston. The company has strategic partnerships to enhance its offerings and reach in the healthcare sector.
Gu Sheng Tang (GST) is a China-based healthcare services provider that operates a chain of private clinics specializing in traditional Chinese medicine.
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation. Bo Zhang and Wei Cheng established the company in 2012 in Beijing, Beijing.
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation. Bo Zhang and Wei Cheng established the company in 2012 in Beijing, Beijing.
Uber China
Series B in 2016
Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber's China unit was acquired by Didi Chuxing in August 2016 after being valued at $7B (pre-money) earlier in the year.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.